279 related articles for article (PubMed ID: 18687307)
1. PKC-dependent extracellular signal-regulated kinase 1/2 pathway is involved in the inhibition of Ib on AngiotensinII-induced proliferation of vascular smooth muscle cells.
Wang Y; Yan T; Wang Q; Wang W; Xu J; Wu X; Ji H
Biochem Biophys Res Commun; 2008 Oct; 375(1):151-5. PubMed ID: 18687307
[TBL] [Abstract][Full Text] [Related]
2. [Ca2+]i and PKC-alpha are involved in the inhibitory effects of Ib, a novel nonpeptide AngiotensinII subtype AT1 receptor antagonist, on AngiotensinII-induced vascular contraction in vitro.
Wang Y; Wang W; Wang Q; Wu J; Xu J; Wu X
Biochem Biophys Res Commun; 2007 Dec; 364(1):118-23. PubMed ID: 17931598
[TBL] [Abstract][Full Text] [Related]
3. Role of Ras/PKCzeta/MEK/ERK1/2 signaling pathway in angiotensin II-induced vascular smooth muscle cell proliferation.
Zhao Y; Liu J; Li L; Liu L; Wu L
Regul Pept; 2005 May; 128(1):43-50. PubMed ID: 15721486
[TBL] [Abstract][Full Text] [Related]
4. C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2.
Walcher D; Babiak C; Poletek P; Rosenkranz S; Bach H; Betz S; Durst R; Grüb M; Hombach V; Strong J; Marx N
Circ Res; 2006 Nov; 99(11):1181-7. PubMed ID: 17068290
[TBL] [Abstract][Full Text] [Related]
5. Src tyrosine kinase regulates angiotensin II-induced protein kinase Czeta activation and proliferation in vascular smooth muscle cells.
Li L; Zhou Y; Wang C; Zhao YL; Zhang ZG; Fan D; Cui XB; Wu LL
Peptides; 2010 Jun; 31(6):1159-64. PubMed ID: 20307614
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of angiotensin II-AT1 receptors during statin withdrawal in vascular smooth muscle cells.
Castejon AM; Zollner E; Tristano AG; Cubeddu LX
J Cardiovasc Pharmacol; 2007 Dec; 50(6):708-11. PubMed ID: 18091590
[TBL] [Abstract][Full Text] [Related]
7. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
Li B; Yang L; Shen J; Wang C; Jiang Z
Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin gallate suppresses proliferation of vascular smooth muscle cells induced by high glucose by inhibition of PKC and ERK1/2 signalings.
Yang J; Han Y; Sun H; Chen C; He D; Guo J; Yu C; Jiang B; Zhou L; Zeng C
J Agric Food Chem; 2011 Nov; 59(21):11483-90. PubMed ID: 21973165
[TBL] [Abstract][Full Text] [Related]
9. Nobiletin, a dietary phytochemical, inhibits vascular smooth muscle cells proliferation via calcium-mediated c-Jun N-terminal kinases pathway.
Zhou CH; Wu XH; Wu YQ
Eur J Pharmacol; 2009 Aug; 615(1-3):55-60. PubMed ID: 19486902
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species.
Meng D; Shi X; Jiang BH; Fang J
Free Radic Biol Med; 2007 Jun; 42(11):1651-60. PubMed ID: 17462533
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
Cirillo P; Calì G; Golino P; Calabrò P; Forte L; De Rosa S; Pacileo M; Ragni M; Scopacasa F; Nitsch L; Chiariello M
Circulation; 2004 Jun; 109(23):2911-6. PubMed ID: 15173027
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II activates intermediate-conductance Ca2+ -activated K+ channels in arterial smooth muscle cells.
Hayabuchi Y; Nakaya Y; Yasui S; Mawatari K; Mori K; Suzuki M; Kagami S
J Mol Cell Cardiol; 2006 Dec; 41(6):972-9. PubMed ID: 16919291
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 90 acts as a molecular chaperone in late-phase activation of extracellular signal-regulated kinase 1/2 stimulated by oxidative stress in vascular smooth muscle cells.
Liu DH; Yuan HY; Cao CY; Gao ZP; Zhu BY; Huang HL; Liao DF
Acta Pharmacol Sin; 2007 Dec; 28(12):1907-13. PubMed ID: 18031603
[TBL] [Abstract][Full Text] [Related]
14. Ferulic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II.
Hou YZ; Yang J; Zhao GR; Yuan YJ
Eur J Pharmacol; 2004 Sep; 499(1-2):85-90. PubMed ID: 15363954
[TBL] [Abstract][Full Text] [Related]
15. Probucol mediates vascular remodeling after percutaneous transluminal angioplasty via down-regulation of the ERK1/2 signaling pathway.
Yang YB; Yang YX; Su B; Tang YL; Zhu BY; Hu ZW; Li GY; Li YJ; Liao DF
Eur J Pharmacol; 2007 Sep; 570(1-3):125-34. PubMed ID: 17628533
[TBL] [Abstract][Full Text] [Related]
16. Differential phosphorylation of calreticulin affects AT1 receptor mRNA stability in VSMC.
Mueller CF; Wassmann K; Berger A; Holz S; Wassmann S; Nickenig G
Biochem Biophys Res Commun; 2008 Jun; 370(4):669-74. PubMed ID: 18413143
[TBL] [Abstract][Full Text] [Related]
17. Pinocembrin inhibits angiotensin II-induced vasoconstriction via suppression of the increase of [Ca2+]i and ERK1/2 activation through blocking AT(1)R in the rat aorta.
Li L; Pang XB; Chen BN; Gao L; Wang L; Wang SB; Wang SB; Liu DP; Du GH
Biochem Biophys Res Commun; 2013 May; 435(1):69-75. PubMed ID: 23611777
[TBL] [Abstract][Full Text] [Related]
18. Iptakalim inhibited endothelin-1-induced proliferation of human pulmonary arterial smooth muscle cells through the activation of K(ATP) channel.
Zhu Y; Zhang S; Xie W; Li Q; Zhou Y; Wang H
Vascul Pharmacol; 2008; 48(2-3):92-9. PubMed ID: 18276195
[TBL] [Abstract][Full Text] [Related]
19. Mechanical stretch potentiates angiotensin II-induced proliferation in spontaneously hypertensive rat vascular smooth muscle cells.
Liu G; Hitomi H; Hosomi N; Lei B; Pelisch N; Nakano D; Kiyomoto H; Ma H; Nishiyama A
Hypertens Res; 2010 Dec; 33(12):1250-7. PubMed ID: 20927110
[TBL] [Abstract][Full Text] [Related]
20. Cystathionine gamma-lyase deficiency and overproliferation of smooth muscle cells.
Yang G; Wu L; Bryan S; Khaper N; Mani S; Wang R
Cardiovasc Res; 2010 Jun; 86(3):487-95. PubMed ID: 20051385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]